Unlocking the power of sugar: carbohydrate ligands as key players in nanotherapeutic-assisted targeted cancer therapy.
Rajan SwamiSahil VijShubham SharmaPublished in: Nanomedicine (London, England) (2024)
Cancer cells need as much as 40-times more sugar than their normal cell counterparts. This sugar demand is attained by the excessive expression of inimitable transporters on the surface of cancer cells, driven by their voracious appetite for carbohydrates. Nanotechnological advances drive research utilizing ligand-directed therapeutics and diverse carbohydrate analogs. The precise delivery of these therapeutic cargos not only mitigates toxicity associated with chemotherapy but also reduces the grim toll of mortality and morbidity among patients. This in-depth review explores the potential of these ligands in advanced cancer treatment using nanoparticles. It offers a broader perspective beyond the usual ways we deliver drugs, potentially changing the way we fight cancer.
Keyphrases
- cancer therapy
- drug delivery
- papillary thyroid
- poor prognosis
- single cell
- small molecule
- oxidative stress
- cardiovascular events
- weight loss
- optical coherence tomography
- weight gain
- cell therapy
- coronary artery disease
- risk assessment
- body mass index
- bone marrow
- radiation therapy
- climate change
- body weight
- lymph node metastasis
- drug induced
- walled carbon nanotubes
- oxide nanoparticles